Completed
Topics
This public workshop provided a venue for stakeholders to discuss the current landscape of rapid diagnostics to address antibiotic resistance, consider challenges and opportunities for spurring innovation, and discuss practical next steps for accelerating the development of new diagnostic tools.
Featured publication
Workshop
·2023
The use and misuse of antibiotics contributes to the rise in drug-resistant bacteria - a serious and worsening threat to human health. The development and use of rapid point-of-care diagnostics in the healthcare setting plays an important role in avoiding unnecessary use of antimicrobials by providi...
View details
Description
A planning committee under the auspices of the National Academies of Sciences, Engineering, and Medicine, will organize a two-day public workshop to discuss the current landscape of rapid diagnostics to address antibiotic resistance, consider challenges and opportunities for spurring innovation, and discuss practical next steps for accelerating the development of new diagnostic tools.
The public workshop will feature invited presentations and discussions to:
- Examine the current state of rapid diagnostic development, including examples of successes and limitations of current approaches.
- Consider the unique challenges for the development and use/uptake of rapid diagnostics (e.g. feasibility of clinical utility studies)
- Consider gaps for which rapid diagnostics may be best-suited to address (e.g. tools to support targeted treatment decisions in the healthcare setting, tools to enable real-time surveillance based on routine hospital data, tools to enable global surveillance).
- Discuss practical short- and long-term opportunities for spurring the development of new diagnostics that can help address antibiotic resistance.
The planning committee will organize the workshop, develop the agenda, select and invite speakers and discussants, and moderate or identify moderators for the discussions. A proceedings of the presentations and discussions at the workshop will be prepared by a designated rapporteur in accordance with institutional guidelines.
Collaborators
Committee
Co-Chair
Co-Chair
Member
Member
Member
Member
Member
Member
Member
Member
Sponsors
American Society of Tropical Medicine and Hygiene
Amgen Inc
Association of American Medical Colleges
AstraZeneca
Biogen
Biomedical Advanced Research and Development Authority (BARDA)
Burroughs Wellcome Fund
Centers for Disease Control and Prevention (CDC)
Critical Path Institute
Department of Health and Human Services
Department of Veterans Affairs
EcoHealth Alliance
Eli Lilly and Company
ExxonMobil
FasterCures, Milken Institute
Foundation for the National Institutes of Health
Friends of Cancer Research
Infectious Diseases Society of America
Johnson & Johnson
Medable
Merck & Co., Inc.
National Cancer Institute
National Center for Advancing Translational Sciences
National Institute of Allergy and Infectious Diseases
National Institute of Mental Health
National Institute of Neurological Disorders and Stroke
National Institutes of Health
New England Journal of Medicine
New Venture Fund
Office of the Assistant Secretary for Preparedness and Response (HHS)
Office of the Director (National Institutes of Health)
Sanofi
Takeda
U.S. Food and Drug Administration
Uniformed Services University of the Health Sciences
Staff
Carolyn Shore
Lead
Lisa Brown
Lead
Scott Wollek
Lead
Julie Liao
Lead
Noah Ontjes
Claire Biffl
Bianca Espinosa
Deanna Giraldi
